AGIO

AGIOS PHARMACEUTICALS INC

AGIO·00847X104·US·Common Stock·Healthcare - Biotechnology-13D/G

AGIO (AGIOS PHARMACEUTICALS INC) is held by 129 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($239.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($219.6M), STATE STREET CORP ($131.1M). Net institutional sentiment: Mixed. In Q2 2026, 2 members of Congress and 80 funds bought AGIO.

129
Holders
(10 Elite)
$1.9B
Total Value
62% (130)
Consensus
80 buying - 50 selling
13F: Insider & Congress: Updated regularly
AGIO

Smart Money Verdict

View all
Loading verdict
Held by 129 funds
10 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 6, 2026 · Activists Aug 3, 2026 · Congress Apr 7, 2026

InsiderGSGheuens SarahSell $914KAug 4, 2026
ActivistDED. E. Shaw & Co., L.P.5.1%Jul 2, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
6.5M(+12.2%)$239.6M0.0%+3.78%
34
Increased
5.9M(+4.1%)$219.6M1.0%+9.64%
50
Increased
3.5M(+5.0%)$131.1M0.0%+19.06%
32
Increased
3.1M(+15.9%)$115.3M0.1%+9.06%
35
Increased
2.9M(+11.0%)$107.6M0.0%-0.48%
33
Increased
2.7M(+1.9%)$99.5M0.0%+0.29%
30
Decreased
2.2M(-20.3%)$82M0.6%-13.12%
0
Increased
2.1M(+41.2%)$78.3M0.1%+12.89%
47
Increased
1.6M(+7.3%)$58.4M0.0%-18.21%
32
Increased
1.4M(+2.3%)$51M0.0%+19.63%
30
Decreased
1.3M(-19.0%)$47.5M0.0%-2.79%
0
Increased
1.2M(+8.4%)$46.3M0.0%+32.18%
32
Increased
1.2M(+42.8%)$42.7M0.0%+0.52%
39
Increased
985,831(+643.8%)$36.6M0.0%-8.37%
47
Decreased
963,256(-0.4%)$35.7M0.0%+0.11%
0
Increased
873,560(+20.9%)$32.4M0.0%+4.29%
35
Increased
810,530(+223.6%)$30.1M0.0%-5.84%
46
Increased
732,687(+18.3%)$27.2M0.0%+11.48%
34
Increased
684,340(+1779.5%)$25.4M0.0%-8.15%
46
Unchanged
612,850$22.7M0.2%+15.60%
0

Showing 1-20 of 141

1 / 8
AGIOAGIOAGIOS PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used